Alvotech (ALVO) Balance Sheet

NASDAQ: ALVOAssets, liabilities, debt and equity over 6 years.

ALVO balance sheet, 2025

December 31, 2025 · U.S. dollars

$1.49B assets = $1.77B liabilities + −$284.5M equity

What it owns$1.49BCash & ST investments: $172.4M (11.6%)$172.4MReceivables: $153.8M (10.3%)Receivables $153.8MInventory: $220.1M (14.8%)Inventory$220.1M · 15%Other current: $27.8M (1.9%)PP&E: $356.4M (24.0%)PP&E$356.4M · 24%Goodwill & intangibles: $94.7M (6.4%)Other non-current: $462.0M (31.1%)Other non-current$462.0M · 31%=How it is financed$1.77BCurrent liabilities: $304.1M (17.2%)Current liabilities$304.1M · 17%Long-term debt: $1.26B (71.2%)Long-term debt$1.26B · 71%Other LT liabilities: $205.4M (11.6%)Other LT liabilities$205.4M · 12%

Liabilities exceed assets: shareholders’ equity is negative (−$284.5M).

Both columns are drawn to the same scale: what ALVO owns equals what it owes plus shareholders’ equity. Hover a block for its value.

ALVO financial health

Current ratio1.89
Comfortable · current assets cover current liabilities 1.89×
Equity / assets−19.1%
Thin equity · of assets funded by shareholders
Cash / debt11.9%
Low cash cover · cash & short-term investments vs total debt
Goodwill & intangibles6.4%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

ALVO balance sheet trends, 2020–2025

Alvotech balance sheet trends
MetricTrendThenLatestChange
Total assets$474.4M2020$1.49B2025+25.7%/yr
Total liabilities$1.34B2020$1.77B2025+5.7%/yr
Shareholders’ equity−$867.2M2020−$284.5M2025—
Cash & short-term investments$31.7M2020$172.4M2025+40.3%/yr
Total debt$676.8M2020$1.45B2025+16.4%/yr
Net cash (debt)−$645.2M2020−$1.28B2025−$631.6M
Working capital$35.2M2020$269.9M2025+$234.8M
Book value per share−$2.852022−$1.022025—
Current ratio1.6920201.892025+0.20
Shares outstanding197.7M2022279.2M2025+12.2%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

ALVO assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

ALVO liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

ALVO debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

ALVO balance sheet

Alvotech annual balance sheet
202520242023202220212020
Assets
Cash & short-term investments$172.4M$51.4M$11.2M$66.4M$17.6M$31.7M
Cash & equivalents$172.4M$51.4M$11.2M$66.4M$17.6M$31.7M
Receivables$153.8M$251.7M$87.2M$71.4M$53.9M$33.1M
Inventory$220.1M$127.9M$74.4M$71.5M$39.1M$9.6M
Other current assets$27.8M$24.0M$22.0M$21.5M$9.3M$11.7M
Total current assets$574.0M$455.0M$194.8M$230.7M$119.8M$86.2M
Property, plant & equipment (net)$356.4M$409.7M$356.6M$268.1M$205.3M$177.0M
Goodwill & intangible assets$94.7M$32.0M$31.1M$37.3M$33.9M$19.8M
Long-term investments$0$0$18.5M$48.6M$55.3M$56.7M
Other non-current assets$462.0M$324.7M$349.0M$243.7M$183.6M$134.9M
Total assets$1.49B$1.22B$950.1M$828.4M$598.0M$474.4M
Liabilities
Accounts payable$126.1M$67.1M$80.6M$49.2M$28.6M$12.0M
Short-term debt$49.0M$42.2M$47.7M$25.1M$10.1M$8.0M
Deferred revenue$30.4M$16.0M$59.2M$36.9M$29.7M$14.2M
Total current liabilities$304.1M$193.4M$260.9M$167.3M$111.8M$51.0M
Long-term debt$1.26B$1.04B$922.1M$744.7M$398.1M$565.4M
Lease obligations$150.1M$121.7M$115.3M$40.5M$122.1M$108.9M
Other long-term liabilities$205.4M$404.9M$699.5M$480.9M$223.6M$725.3M
Total liabilities$1.77B$1.63B$1.88B$1.39B$733.6M$1.34B
Shareholders' equity
Common stock & paid-in capital$2.9M$2.8M$2.3M$2.1M$135,000$73,000
Retained earnings (deficit)−$2.41B−$2.44B−$2.21B−$1.65B−$1.14B−$1.04B
Accumulated other comprehensive income$16.7M$15.1M$41.4M$29.1M$4.7M$5.0M
Total shareholders' equity−$284.5M−$412.8M−$932.5M−$564.4M−$135.6M−$867.2M
Key figures
Total debt$1.45B$1.19B$1.08B$805.1M$523.1M$676.8M
Net cash (debt)−$1.28B−$1.14B−$1.06B−$738.7M−$505.5M−$645.2M
Working capital$269.9M$261.6M−$66.1M$63.4M$8.0M$35.2M
Tangible book value−$379.2M−$444.7M−$963.6M−$601.7M−$169.5M−$887.0M
Book value per share−$1.02−$1.54−$4.10−$2.85——
Shares outstanding279.2M267.9M227.3M197.7M——
Current ratio1.892.350.751.381.071.69
Quick ratio1.071.570.380.820.641.27
Equity / assets−19.1%−33.8%−98.1%−68.1%−22.7%−182.8%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 31, 2026); data from EODHD.

ALVO financial position

At the end of fiscal 2025 (December 31, 2025), Alvotech had total assets of $1.5 billion (up 21.8% from a year earlier), total liabilities of $1.8 billion and shareholders' equity of -$284.5 million. It held $172.4 million in cash and short-term investments against $1.4 billion of debt, net debt of $1.3 billion. Its current ratio was 1.89. In the latest quarter (ended June 30, 2026) total assets were $1.6 billion and equity -$191.5 million.

Related: ALVO income statement, ALVO cash flow statement, ALVO key metrics. See the ALVO stock overview for the latest quote and news.

ALVO balance sheet FAQ

What are Alvotech's total assets?

Alvotech reported total assets of $1.5 billion at the end of fiscal 2025 (December 31, 2025), compared with $1.2 billion a year earlier.

How much debt does Alvotech have?

Alvotech had $1.4 billion of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.

How much cash does Alvotech have?

Alvotech held $172.4 million in cash and short-term investments at the end of fiscal 2025; with $1.4 billion of debt that is net debt of $1.3 billion.

What is Alvotech's book value?

Alvotech's shareholders' equity (book value) was -$284.5 million at the end of fiscal 2025, or −$1.02 per share.

What is Alvotech's current ratio?

Alvotech had current assets of $574.0 million and current liabilities of $304.1 million, a current ratio of 1.89 (it can cover its short-term obligations).

How much goodwill does Alvotech have?

Alvotech carried $94.7 million of goodwill and intangible assets, 6.4% of total assets, at the end of fiscal 2025.

Drug Manufacturers - Specialty & Generic: balance sheet